10 x CA125 OVARIAN CANCER (P)
Guaranteed Irish – Fast, Tracked Delivery Nationwide
All orders dispatch directly from Ireland with premium tracked delivery via An Post or UPS.
Delivery as fast as 1 business day (depending on method chosen).
Order by 2:00 pm for same-day dispatch (10:00 am with An Post).
- Typical delivery: 1–2 working days nationwide
- Saturday delivery available on some routes
- Always shipped in discreet, unmarked packaging
- Tracking updates sent by email and text
T&Cs apply. See full delivery details here
World Class Customer Support & Lifetime Product Support
We want you to know that once you purchase a product from Minilabhealthcare.com you immediately fall under our support umbrella. If you purchased a product 5 days ago or 5 years ago we are here to give advice and support. We are available 9 am to 5pm Monday to Friday GMT.
For all the ways to get in touch by phone, email or support ticket please click here
Hassle Free Returns
We endeavour to make returning your products as easy as possible. Returning your online shopping has never been faster or easier. Book a return and choose to have your item collected or drop it off at your nearest post office or other available drop-off location. For full details on returns please visit our returns page here
Features and Benefits:
- Provides simple positive or negative results for CA125 levels in blood.
- Read results in 10 minutes
- Fully CE approved for professional use
- Minimum 6 months to expiry
Please Note: For professional use only, NO lancets are provided.
What is CA-125?
CA-125 is the most frequently used prognostic biomarker for ovarian cancer detection. Around 90% of women with advanced ovarian cancer have elevated levels of CA-125 in their blood serum, making CA-125 a useful tool for detecting ovarian cancer after the onset of symptoms. Monitoring CA-125 blood serum levels is also useful for determining how ovarian cancer is responding to treatment (with the duration of disease-free survival correlating with the rate of fall of CA-125) and for predicting a patient’s prognosis after treatment.
This is because the persistence of high levels of CA-125 during therapy is associated with poor survival rates in patients. Additionally, an increase in CA-125 levels within individuals in remission is a strong predictor of the recurrence of ovarian cancer.
| Price | €148.63 |
|---|












